Boothbay Fund Management’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,075	Closed	-$121K	–	2041
2023 Q1	$121K	Buy	13,075 +1,936	+17%	+$17.9K	﹤0.01%	1627
2022 Q4	$98.8K	Buy	+11,139	New	+$98.8K	﹤0.01%	1550